Skip to content

Clinical trials

Phase 3 Hyperlipidemias trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Country / region: Denmark Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20137
20141
20151
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Pfizer3
AstraZeneca2
Novartis Pharmaceuticals2
Arrowhead Pharmaceuticals1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias14
Hypercholesterolemia7
Cardiovascular Diseases3
Dyslipidemias3
Homozygous Familial Hypercholesterolemia3
Myocardial Infarction3
Stroke3
Hyperlipoproteinemia Type II2
Atherosclerosis1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.